The pleiotropic effects of glutamine metabolism in cancer

Alex J. Bott, Sara Maimouni, Wei Xing Zong

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Metabolic programs are known to be altered in cancers arising from various tissues. Malignant transformation can alter signaling pathways related to metabolism and increase the demand for both energy and biomass for the proliferating cancerous cells. This scenario is further complexed by the crosstalk between transformed cells and the microenvironment. One of the most common metabolic alterations, which occurs in many tissues and in the context of multiple oncogenic drivers, is the increased demand for the amino acid glutamine. Many studies have attributed this increased demand for glutamine to the carbon backbone and its role in the tricarboxylic acid (TCA) cycle anaplerosis. However, an increasing number of studies are now emphasizing the importance of glutamine functioning as a proteogenic building block, a nitrogen donor and carrier, an exchanger for import of other amino acids, and a signaling molecule. Herein, we highlight the recent literature on glutamine’s versatile role in cancer, with a focus on nitrogen metabolism, and therapeutic implications of glutamine metabolism in cancer.

Original languageEnglish (US)
Article number770
JournalCancers
Volume11
Issue number6
DOIs
StatePublished - Jun 2019

Fingerprint

Glutamine
Neoplasms
Nitrogen
Cellular Microenvironment
Amino Acids
Citric Acid Cycle
Biomass
Carbon
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Keywords

  • Cancer
  • Glutamate
  • Glutamate ammonia ligase (GLUL)
  • Glutaminase (GLS)
  • Glutamine
  • Glutamine synthetase (GS)
  • Glutaminolysis
  • Metabolism

Cite this

Bott, Alex J. ; Maimouni, Sara ; Zong, Wei Xing. / The pleiotropic effects of glutamine metabolism in cancer. In: Cancers. 2019 ; Vol. 11, No. 6.
@article{4591c3b50ec44fc5bcf9248003f5cf19,
title = "The pleiotropic effects of glutamine metabolism in cancer",
abstract = "Metabolic programs are known to be altered in cancers arising from various tissues. Malignant transformation can alter signaling pathways related to metabolism and increase the demand for both energy and biomass for the proliferating cancerous cells. This scenario is further complexed by the crosstalk between transformed cells and the microenvironment. One of the most common metabolic alterations, which occurs in many tissues and in the context of multiple oncogenic drivers, is the increased demand for the amino acid glutamine. Many studies have attributed this increased demand for glutamine to the carbon backbone and its role in the tricarboxylic acid (TCA) cycle anaplerosis. However, an increasing number of studies are now emphasizing the importance of glutamine functioning as a proteogenic building block, a nitrogen donor and carrier, an exchanger for import of other amino acids, and a signaling molecule. Herein, we highlight the recent literature on glutamine’s versatile role in cancer, with a focus on nitrogen metabolism, and therapeutic implications of glutamine metabolism in cancer.",
keywords = "Cancer, Glutamate, Glutamate ammonia ligase (GLUL), Glutaminase (GLS), Glutamine, Glutamine synthetase (GS), Glutaminolysis, Metabolism",
author = "Bott, {Alex J.} and Sara Maimouni and Zong, {Wei Xing}",
year = "2019",
month = "6",
doi = "10.3390/cancers11060770",
language = "English (US)",
volume = "11",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "6",

}

The pleiotropic effects of glutamine metabolism in cancer. / Bott, Alex J.; Maimouni, Sara; Zong, Wei Xing.

In: Cancers, Vol. 11, No. 6, 770, 06.2019.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The pleiotropic effects of glutamine metabolism in cancer

AU - Bott, Alex J.

AU - Maimouni, Sara

AU - Zong, Wei Xing

PY - 2019/6

Y1 - 2019/6

N2 - Metabolic programs are known to be altered in cancers arising from various tissues. Malignant transformation can alter signaling pathways related to metabolism and increase the demand for both energy and biomass for the proliferating cancerous cells. This scenario is further complexed by the crosstalk between transformed cells and the microenvironment. One of the most common metabolic alterations, which occurs in many tissues and in the context of multiple oncogenic drivers, is the increased demand for the amino acid glutamine. Many studies have attributed this increased demand for glutamine to the carbon backbone and its role in the tricarboxylic acid (TCA) cycle anaplerosis. However, an increasing number of studies are now emphasizing the importance of glutamine functioning as a proteogenic building block, a nitrogen donor and carrier, an exchanger for import of other amino acids, and a signaling molecule. Herein, we highlight the recent literature on glutamine’s versatile role in cancer, with a focus on nitrogen metabolism, and therapeutic implications of glutamine metabolism in cancer.

AB - Metabolic programs are known to be altered in cancers arising from various tissues. Malignant transformation can alter signaling pathways related to metabolism and increase the demand for both energy and biomass for the proliferating cancerous cells. This scenario is further complexed by the crosstalk between transformed cells and the microenvironment. One of the most common metabolic alterations, which occurs in many tissues and in the context of multiple oncogenic drivers, is the increased demand for the amino acid glutamine. Many studies have attributed this increased demand for glutamine to the carbon backbone and its role in the tricarboxylic acid (TCA) cycle anaplerosis. However, an increasing number of studies are now emphasizing the importance of glutamine functioning as a proteogenic building block, a nitrogen donor and carrier, an exchanger for import of other amino acids, and a signaling molecule. Herein, we highlight the recent literature on glutamine’s versatile role in cancer, with a focus on nitrogen metabolism, and therapeutic implications of glutamine metabolism in cancer.

KW - Cancer

KW - Glutamate

KW - Glutamate ammonia ligase (GLUL)

KW - Glutaminase (GLS)

KW - Glutamine

KW - Glutamine synthetase (GS)

KW - Glutaminolysis

KW - Metabolism

UR - http://www.scopus.com/inward/record.url?scp=85070680408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070680408&partnerID=8YFLogxK

U2 - 10.3390/cancers11060770

DO - 10.3390/cancers11060770

M3 - Review article

AN - SCOPUS:85070680408

VL - 11

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 6

M1 - 770

ER -